FDA approves Arkray’s new glucose monitoring system
EDINA, Minn. A manufacturer of diabetes self-monitoring systems announced that it received clearance from the Food and Drug Administration for its new Glucocard Vital blood glucose monitoring system.
Arkray said its new meter and strip platform, which will be available for distribution in early December, is expected to be a significant complement to the existing Glucocard line of products, and will be ideal for the home medical equipment, durable medical equipment, mail-order and managed care markets.
“We’re very excited about the latest addition to our Glucocard brand,” said Jonathan Chapman, president of Arkray USA. “The Vital meets all of Arkray’s rigorous design and performance standards. And we can offer it at a price point that will make it an ideal solution for our customers to use in competitive bidding.”
The new Glucocard Vital meter and strip platform is highly accurate, auto-coded, requires only 0.5 microliter of blood, holds 250 dowloadable tests in its memory and has a glucose oxydase strip chemistry that is not affected by interferences that cause testing errors in other common test strips.
The Vital, along with all Glucocard brands, is backed by Arkray’s unique YouChoose wellness program, a comprehensive education and support system that includes printed tools, videos, recipes and an integrated Web site designed to help patients manage their diabetes.
Donnenfeld joins Advanced Vision Research
WOBURN, Mass. Advanced Vision Research named Eric Donnenfeld to the post of chief medical officer.
“Donnenfeld is one of the pre-eminent ophthalmologists practicing today with a broad scope of experience and knowledge,” stated Leigh Reynolds, Advanced Vision COO. “He is a key thought leader who will play a critical role for Advanced Vision Research as we move forward with new product research and development,” he said.
Donnenfeld has been a leader in ophthalmology for more than 20 years, the eye-care company stated. He is on the editorial board of nine medical journals, and is one of the authors of the American Academy of Ophthalmology’s Refractive Surgery Basic Science Book. Donnenfeld graduated with honors at the top of his class at Dartmouth Medical School. He was chief resident at Manhattan Eye Ear and Throat Hospital and he completed his Cornea and Refractive Fellowship at Wills Eye Hospital in Philadelphia.
PDS Health launches diabetes, heart disease monitoring and management service
JUPITER, Fa. PDS Health on Monday announced the launch of wireless hardware diagnostics that work seamlessly with MDMonitor.com online software to monitor diabetes and heart disease.
“The name of the new wireless device is Celemonitor and it can submit the readings from patients’ glucose meters, blood pressure monitors and scales from anywhere,” the company stated.
The readings and data pertaining to the patient’s health is collected to MDMonitor.com and a designated caregiver can access the data.